New device aims to prevent leaks after colon cancer surgery
NCT ID NCT06402188
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a device called ColoSeal ICD that is placed inside the colon after surgery to divert stool away from the surgical connection. The goal is to see if it is safe and feasible in 90 adults with rectal or rectosigmoid cancer. The device stays in place for about 10 days and is then removed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ColoSeal ICD Device (a temporary tube placed in the colon to divert stool away from a surgical connection)
What this could lead to
If it works, this device could reduce the risk of serious leaks after colon surgery, potentially making recovery safer and faster.
What could go wrong
This is an early feasibility study with only 90 participants, so results may not apply to everyone. The device could cause infection, migration, or other complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Israeli-Georgian Medical Research Clinic Healthycore
COMPLETEDTbilisi, 0112, Georgia
-
National Cancer Institute
RECRUITINGTashkent, Uzbekistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
National Center of Oncology after V.A. Fanarjian
RECRUITINGYerevan, Armenia
Contact Phone: •••-•••-•••• Email: •••••@•••••